Surge in prevalence of arthritis, demand by sportsperson and athletes, and fewer side effects as compared to oral medicines drive the U.S. topical pain relief market.
Surge in prevalence of arthritis, demand by sportsperson and athletes, and fewer side effects as compared to oral medicines drive the U.S. topical pain relief market.
The U.S. topical pain relief industry generated $2.61 billion in 2019, and is expected to reach $3.27 billion by 2027, witnessing a CAGR of 3.7% from 2020 to 2027.
Drivers, restraints, and opportunities
Surge in prevalence of arthritis, demand by sportsperson and athletes, and fewer side effects as compared to oral medicines drive the U.S. topical pain relief market. However, skin irritations caused by topical pain relief products and unpleasant odor hinder the market growth. On the other hand, emergence of online pharmacy presents new opportunities in the coming years.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5356
Covid-19 Scenario
- Most of the chronic pain facilities were considered non-urgent and both outpatient and elective interventional procedures were restricted or stopped completely during the Covid-19 pandemic for reducing the risk of the viral spread.
- During the post-lockdown, large number of clinics and pain services witnessed a plunge in the number of patient visits for reducing the possibility of cross-contamination.
- Many distribution channels such as pharmacies & drug stores and retail & grocery stores were closed during the lockdown. However, the demand for topical pain relief products is expected to increase as lockdown restrictions are lifted off in many states.
The non-opioids segment to continue its lead position throughout the forecast period
Based on therapeutic class, the non-opioids segment held the largest market share, accounting for more than two-thirds of the U.S. topical pain relief market in 2019, and is expected to continue its lead position throughout the forecast period. Moreover, this segment is estimated to grow at the highest CAGR of 3.9% from 2020 to 2027. This is due to fewer side effects as compared to opioids and improbability of substance abuse. The report also analyzes the opioids segment.
The prescription pain relief segment to maintain its leadership status during the forecast period
Based on type, the prescription pain relief segment contributed to the highest share in 2019, accounting for nearly four-fifths of the U.S. topical pain relief market, and is expected to maintain its leadership status during the forecast period. This is due to offering of correct number of drugs for treatment of pain without causing much of the side effects. However, the over-the-counter pain relief segment is expected to witness the highest CAGR of 3.8% from 2020 to 2027, owing to factors such as low cost of OTC products and difficulty in getting appointments with healthcare professionals.
The pharmacies & drug stores segment to maintain its dominant position by 2027
Based on distribution channel, the pharmacies & drug stores segment held the highest share in terms of revenue in 2019, accounting for more than two-thirds of the U.S. topical pain relief market, and will maintain its dominant position by 2027. This is attributed to the offering of a diverse set of drugs and services at different pharmacy outlets, independent drugstores, supermarkets with pharmacies, chain drugstores, and mass merchants with pharmacies. However, the e-commerce segment is projected to register the fastest CAGR of 3.8% during the forecast period, owing to surge in digital literacy among the population and various advantages such as fewer expenses, more convenience, price comparisons, and easy access to patient reviews.
Access Full Report: https://www.alliedmarketresearch.com/us-topical-pain-relief-market
Leading market players:
- Advacare Pharma
- Glaxosmithkline Plc (GSK)
- Johnson & Johnson
- Nestlé S.A.
- Novartis AG
- Pfizer Inc.
- Reckitt Benckiser Group Plc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Topical Biomedics, Inc.
Trending Reports:
Philippines Wound Care Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
Forensic Technology Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch (dot) com